GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VBI Vaccines Inc (STU:LO9A) » Definitions » 3-Year EPS without NRI Growth Rate

VBI Vaccines (STU:LO9A) 3-Year EPS without NRI Growth Rate : 13.90% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is VBI Vaccines 3-Year EPS without NRI Growth Rate?

VBI Vaccines's EPS without NRI for the three months ended in Mar. 2024 was €-0.51.

During the past 3 years, the average EPS without NRI Growth Rate was 13.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 25.10% per year. During the past 10 years, the average EPS without NRI Growth Rate was 18.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of VBI Vaccines was 55.60% per year. The lowest was -218.30% per year. And the median was 9.05% per year.


Competitive Comparison of VBI Vaccines's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, VBI Vaccines's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VBI Vaccines's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VBI Vaccines's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where VBI Vaccines's 3-Year EPS without NRI Growth Rate falls into.



VBI Vaccines 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


VBI Vaccines  (STU:LO9A) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


VBI Vaccines 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of VBI Vaccines's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


VBI Vaccines (STU:LO9A) Business Description

Industry
Traded in Other Exchanges
Address
160 Second Street, Floor 3, Cambridge, MA, USA, 02142
VBI Vaccines Inc is a US-based commercial-stage, the biopharmaceutical company which is engaged in developing next-generation vaccines to address unmet needs in infectious disease and immuno-oncology. The company manufactures Sci-B-Vac product which is a hepatitis B (HBV) vaccine for adults, children, and newborns. Its products include Virus-Like Particle which is vaccine platform which allows for the design of enveloped virus-like particle vaccines that closely mimic the target viruses. The company operates through the single segment being Developing vaccines to address unmet needs in infectious disease and immuno-oncology.

VBI Vaccines (STU:LO9A) Headlines

No Headlines